We have previously shown that targeted deletion of the Tnfaip3 gene, encoding the NF-κB regulator A20, specifically in type I conventional dendritic cells (cDC1s), is sufficient to induce PAH symptoms in mice. The gene discussed is TNFAIP3; the disease is pulmonary arterial hypertension.